Similar articles

• Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan.

  Hardy OT, Hernandez-Pampaloni M, Saffer JR, Suchi M, Ruchelli E, Zhuang H, Ganguly A, Freifelder R, Adzick NS, Alavi A, Stanley CA. Hardy OT, et al. J Pediatr. 2007 Feb;150(2):140-5. doi: 10.1016/j.jpeds.2006.08.028. J Pediatr. 2007. PMID: 17236890
• Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism.

  Capito C, Khen-Dunlop N, Ribeiro MJ, Brunelle F, Aigrain Y, Crétolle C, Jaubert F, De Lonlay P, Nihoul-Fékété C. Capito C, et al. Radiology. 2009 Oct;253(1):216-22. doi: 10.1148/radiol.2532081445. Epub 2009 Aug 25. Radiology. 2009. PMID: 19709999
• The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy.

  Zani A, Nah SA, Ron O, Totonelli G, Ismail D, Smith VV, Ashworth M, Blankenstein O, Mohnike W, De Coppi P, Eaton S, Hussain K, Pierro A. Zani A, et al. J Pediatr Surg. 2011 Jan;46(1):204-8. doi: 10.1016/j.jpedsurg.2010.09.093. J Pediatr Surg. 2011. PMID: 21238668
• Role of 18F-DOPA PET/CT imaging in congenital hyperinsulinism.

  Ismail D, Hussain K. Ismail D, et al. Rev Endocr Metab Disord. 2010 Sep;11(3):165-9. doi: 10.1007/s11154-010-9145-1. Rev Endocr Metab Disord. 2010. PMID: 20878481 Review.
• 18-F-L 3,4-Dihydroxyphenylalanine PET/Computed Tomography in the Management of Congenital Hyperinsulinism.

  States LJ, Saade-Lemus S, De Leon DD. States LJ, et al. PET Clin. 2020 Jul;15(3):349-359. doi: 10.1016/j.cpet.2020.03.004. PET Clin. 2020. PMID: 32498990 Review.